Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
Non-alcoholic fatty liver disease (NAFLD) constitutes the most common liver disease worldwide, and is frequently linked to the metabolic syndrome. The latter represents a clustering of related cardio-metabolic components, which are often observed in patients with NAFLD and increase the risk of cardi...
Guardado en:
Autores principales: | Sue Shea, Christos Lionis, Chris Kite, Lou Atkinson, Surinderjeet S. Chaggar, Harpal S. Randeva, Ioannis Kyrou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5860547aea9e4ee9a5effc8cee9f7d89 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum
por: Chen HW, et al.
Publicado: (2021) -
Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
por: Daniela Maria Tanase, et al.
Publicado: (2021) -
Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis
por: Sang R. Lee, et al.
Publicado: (2018) -
Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment
por: Chengyuan Liang, et al.
Publicado: (2021) -
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
por: Rocío Gallego-Durán, et al.
Publicado: (2021)